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1. Introduction  
Transfusion-associated bacterial sepsis (TABS) is caused by bacteria present in blood 
components. It is one of the earliest recognized adverse transfusion-associated reactions. 
Blood components most often become contaminated while blood is being collected from a 
donor; more seldom in the case of asymptomatic bacteremia or erroneous blood processing 
procedures (1). Although the risk for transfusion-associated bacterial sepsis has diminished 
considerably since the introduction of new methods of bacteria detection and of increasingly 
better means of skin disinfection, reappearing reports about severe or fatal reactions after 
contaminated blood component transfusions prove that the problem is still very serious. 
Most often bacterial contamination affects red blood cell concentrates and platelet 
concentrates. There have been cases reported of bacterially contaminated plasma or 
cryoprecipitate, although bacteria do not proliferate in these components when they are 
stored (1,2). Of note, bacterial sepsis is an adverse reaction not only after allogenic 
transfusions but also after autologous ones. 
Bacteria are very rarely transmitted during blood component transfusion, but if they are, 
they usually cause severe, life-threatening adverse reactions, with the mortality rate of 20 – 
30%. In USA, bacteria transmission during transfusion is the second (just after 
“administrative error”) most common cause of fatal transfusion-associated reactions. It is 
estimated that every year 100 – 150 patients undergoing blood component transfusion die 
because of that (1). This number is probably underestimated. There are a few causes of this 
situation. Tests which can confirm or exclude the infectious background of adverse reactions 
occurring during or right after transfusion are not always performed. Besides, the 
organism’s response to infection may be misinterpreted as a manifestation of the underlying 
disease or another non-infectious transfusion-associated reaction. That is why the estimated 
prevalence of fatal adverse reactions may be overestimated because the adverse reactions 
that have the most severe course are predominantly reported to the relevant registering 
centers. 
The risk for transfusion-associated bacterial sepsis results from the nature of pathogens 
themselves and from determinants connected with blood donors and recipients. 
From the transfusiology point of view, the characteristic features of infectious agents include 
their biology, the course of infection, the degree of infectivity, and how harmful they are for 
the recipient if transfusion-associated bacterial infection occurs. The crucial issues are whether: 
• An infectious agent is present in blood in the course of infection, how long it has been 
there, at what concentration; 
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• An infectious agent is transmitted via transfusion. Can its transfusion infectiveness be 
limited and how? 
• In a particular population, an infectious agent is highly prevalent or not. Consequently, 
how many recipients are infected with it via other ways than blood component 
transfusions? How prevalent this infection is among donors and whether identifying 
uninfected donors is possible and feasible. 
• An infectious agent causes a severe disease if it is transmitted with blood. Is the disease 
potentially lethal? What are the possibilities of treating the recipient who has acquired 
the disease?  
The infectious agents important from the transfusiology point of view are those which are 
asymptomatic enough so that a donor would not report them before donation. 
Infectious agents can be present only in some blood components. There are bacteria that are 
observed in the free form in plasma. An important parameter is also how infectious agents 
behave in the conditions at which blood is stored. These conditions differ for various blood 
components. The whole blood, its cellular components, plasma or plasma-derived 
preparations are stored in different forms, e.g. liquid or frozen at -25oC to +24oC. Most 
bacteria are able to proliferate in the components stored. There are also such that are very 
sensitive and quickly die once they are outside the host’s organism. They include Treponema 
pallidum, which cannot survive longer than 72 hours at +4oC. The fact that bacteria have 
been transmitted with blood does not necessarily mean that the recipient will fall ill. To a 
large extent, it depends on the amount of the infectious agent, i.e. how much of the blood 
component has been transfused and how big concentration of the pathogen was in the 
component. Whether a recipient will fall ill depends on the recipient’s immune condition 
and the possibility to control the infection (3,4,). Table 1 itemizes what promotes 
transfusion-associated bacterial sepsis development. 
 
• Volume of blood component transfused 
• Bacteria concentration in blood component 
• Immune and general conditions of recipient 
• Extent of surgery, type of invasive diagnostic procedures 
• Intensity of recipient monitoring 
• Mode of treatment (antibiotics) 
Table 1. Parameters promoting sepsis development following transfusion of bacteria 
contaminated blood components (5). 
2. Causes of transfusion-associated bacterial sepsis 
The sources of bacterial infections may be endogenous or exogenous. Bacteremia in a donor 
may be an endogenous source of blood sample contamination. Chronic bacteremia is 
observed in syphilis. Being a carrier of Borrelia burgdorferi, responsible for borreliosis, a tick-
derived disease, or Brucella abortus, may also be associated with risk. Bacteremia 
accompanying alimentary tract infections and alimentary toxicosis in donors is caused by 
such bacteria as Salmonella but is very rare. In order to exclude them, it is important to take a 
comprehensive history of the donor.  
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Another cause of bacterial contamination of the blood collected may be by bacteria present 
on the donor’s skin when a needle is inserted into a vein or contamination during blood 
collection or processing of blood components. 
The risk an infection is transmitted with a blood component depends mainly on the 
conditions and time a component has been stored before it is transfused to a patient.  It is 
much higher when platelet concentrates are used than in the case of red blood cell 
concentrates, mainly due to the storage temperature. The risk exists when it is stored in a 
temperature which is suitable for bacterial survival and proliferation. Platelets are the 
component that is stored in the conditions which promote bacterial proliferation (room 
temperature). Red blood cells, stored at +4oC, are much less dangerous, and in the case of 
plasma or cryoprecipitate transfusion, the risk for bacterial complications is almost nil. 
Plasma is frozen, after it is processed at  -30oC or lower, which practically eliminates the 
possibility for bacteria to survive. Table 2 presents possible causes of blood component 
bacterial contamination. 
 
• Asymptomatic bacteremia in donor 
• Inadequate disinfection of venopuncture site 
• Donor’s skin fragment placed in blood container (via needle) 
• Contaminated blood sampling kit or anticoagulant 
 
- Faulty sterilization 
- Wrong storing 
Table 2. Causes of bacterial contamination of blood components 
Bacterial proliferation in a blood sample is limited considerably by antibacterial features of 
blood itself. Bacteria are destroyed by the complement and phagocytized by blood 
leukocytes. The risk of donor-derived infection is lower after the leukocytes which have 
phagocytized bacteria in blood have been removed. 
The severity of adverse transfusion-associated bacterial reactions which may occur in a 
recipient after a contaminated blood component has been transfused depends on many 
factors, which are presented in Table 3. 
 
• Number of bacteria (dose) 
• Types of bacteria (Gram-positive, Gram-negative) 
• Virulence of bacteria – production of exotoxins and endotoxins 
• Recipient’s general condition (immune system functioning, underlying 
disease) 
• Recipient undergoing antibiotic therapy 
Table 3. Factors influencing the severity of transfusion-associated adverse infectious 
reactions in recipients 
Certain regularity is the fact that the risk for transfusion-associated septic reactions is 
directly proportional to the duration and temperature at which blood and its components 
are stored. Some bacteria die or cannot proliferate in the temperature at which blood 
components are stored. Yet such cryophilic bacteria as Yersinia enterocolitica survive in red 
blood concentrates because low temperatures do not act destructively on them. Platelet 
concentrates, which are stored in room temperature, are a more friendly environment for 
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bacteria to survive and proliferate although some, more sensitive ones, die at 20 – 240C. 
Most Gram-positive and Gram-negative bacteria are able to survive and proliferate in 
platelet concentrates. 
In most reported cases of transfusion-associated bacterial sepsis, the sources of blood 
component contaminations were not identified. Yet the type of bacteria responsible for the 
complications enabled the probable cause of sepsis and hypothetical source of pathogenic 
bacteria to be established. For example, coagulase-negative Staphylococci or Corynebacteria in 
platelet concentrates suggest the epidermal origin, but Streptococcus viridans in blood most 
likely originates from a donor undergoing dentistry procedures. 
2.1 Bacterial infections transmitted with red blood cell concentrates 
Red blood cell concentrate is a blood component, which is transfused most frequently.  
It does not contain only red blood cells but also various amounts of platelets and leukocytes. 
Transfusion-associated bacterial sepsis resulting from transfusing a bacterially contaminated 
red blood cell concentrate is rather uncommon. Different reports estimate its rate  
at 1:250,000 transfusions; the relevant sepsis mortality rate ranges 58 – 70% (5). During nine 
years, FDA registered 25 fatalities due to transfusion of contaminated red blood  
cell concentrate (6). Thus, the mortality risk is estimated at 13:1,000,000 red blood  
cell concentrate transfusions (7). On the other hand, the Dana Farber Cancer Institute studies 
have found the infection prevalence at 1:38,000 transfused red blood cell concentrate  
units (8,9). 
The bacterium most commonly responsible for sepsis associated with red blood cell 
concentrate transfusion is Yersinia enterocolitica. The prevalence of sepsis associated with Y. 
enterocolitica transmitted with blood varies. In New Zealand, it is 1:65,000 transfusions, with 
the sepsis fatality rate estimated at 1:104,000 transfused red blood cell concentrate units (4). 
In USA, 20 cases were reported of Yersinia being transmitted with blood components in 1987 
– 1996. Twelve of them died before the 37th day following the transfusion of contaminated 
red blood cell concentrate. The mean time between transfusion and recipient’s death is 25 
hours (10). Yersinia enterocolitica is a Gram-negative bacterium, responsible for diarrheal 
diseases; it may also temporarily colonize the alimentary tract of asymptomatic people. The 
feature characteristic of Yersinia bacteria is their ability to survive and proliferate in 
temperatures in which red blood cell concentrates are stored, i.e. +2 – +6 oC. For their own 
metabolism they also use citrate as the source of carbon, which is an additional factor 
conducive for bacterial proliferation. Citrate compounds are included in commonly used 
anticoagulants. Yersinia bacteria present in a blood component are a typical example of 
endogenous contamination resulting from asymptomatic donor’s bacteremia. A study has 
shown that around 2/3 of donors, in whom Yersinia enterocolitica was detected, had 
complained of gastrointestinal disorders in the time preceding blood donation. Most often 
these ailments had a mild course (9,11,12,13,14). Yersinia may remain in the circulation, 
inside leukocytes, even for a few days after intestinal complaints subside. This bacterium is 
also resistant to the action of complement components and to phagocytosis due to the 
presence of Yersinia outer proteins (Yops) (15,16). 
The likelihood of transmitting bacteria via red blood cell transfusion is directly associated 
with the duration of their storing. Tests of red blood cell concentrates that had been 
contaminated with Yersinia showed that in the 38th day after blood donation, the number of 
bacteria reached 108 – 109 CFU/ml. Between the 21st and 34th days, bacteria very quickly 
proliferated and released endotoxin, whose concentration reached around 315 µg/ml (17). 
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Except for Yersinia enterocolitica, the bacteria which may contaminate red blood cell 
concentrates and potentially cause an endotoxic shock, are Pseudomonas spp., Serratia spp., 
Enterobacter spp., Campylobacter spp. and Escherichia coli  (15). 
Pseudomonades are Gram-negative bacteria commonly found in water and soil. They can 
proliferate in temperature 4oC. They often contribute to red blood cell concentrate 
contamination during concentrate preparation (18). Serratia marcescens was a causative factor 
in transfusion-associated sepsis reported in Denmark and Sweden, where bacterially 
contaminated containers were used at blood donations (19). 
Serratia is also a Gram-negative bacterium, which proliferates easily in poor environment at 
+4 – +22oC. The bacteria were isolated from both red blood cell concentrates and platelets 
concentrates. Transmitting Serratia, especially Serratia liquefaciens, causes transfusion-
associate sepsis, most often fatal (1,20).  
A prospective analysis of bacterial cultures from whole blood and red blood cell 
concentrates has shown that bacterial contamination is much more common in blood 
components, i.e. 2 – 4 per 4,000 units. The bacteria most often cultured were Staphylococcus 
and Propionibacterium spp. They very rarely cause sepsis in recipients because they do not 
proliferate at +2 – +6 oC, and red blood cells are stored just at this temperature range. Table 4 
shows bacteria found in red blood cell concentrates. 
 
Blood component Bacteria 
Prevalence of bacteria 
detected that caused 
complications  
Red blood cell 
concentrate 
Yersinia enterocolitica  
Pseudomonas fluorescens 
Pseudomonas putida 
Treponema pallidum 
Other bacteria 
51.0% 
26.5% 
4.1% 
4.1% 
14.3% 
Table 4. Bacteria detected in red blood cell concentrates 
There have been also two fatal cases of transfusion-associated sepsis described caused by 
Pantoeae agglomerans, which used to be known as Enterobacter agglomerans (21). That 
bacterium possesses plasmid-associated factors, which make it resistant to phagocytosis 
(22,23).  
Autologous blood is also a source of severe transfusion-associated sepsis. There are cases 
reported in the literature describing transmitting Y.enterocolitica infection following 
autologous transfusion (12,23). In Japanese studies, a common bacterium contaminating 
blood from autologous transfusions was coagulase-negative Staphylococcus (24,25). 
2.2 Bacterial infections transmitted by contaminated platelet concentrate 
The risk for being infected with bacteria in transfused platelets is 50 to 250 times higher than 
that associated with red blood cell transfusions (26). 
In platelet concentrate transfusion-associated sepsis, bacteria belonging to the donor’s skin 
flora are the main infectious factor. Thus, they are typical exogenous infections resulting 
from badly disinfected skin in the site of needle insertion. The bacteria most commonly 
contaminating platelet concentrates are Staphylococcus epidermidis, which constitutes over 
50% of all bacteria detected and Bacillus cereus, which belong to the physiological skin flora 
(27,28). These bacteria do not proliferate at 0oC, but are able to proliferate in the temperature 
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at which platelets are stored, i.e. 20 – 24oC. If the course of the infection associated with 
platelet transfusion is rapid, mainly Gram-negative bacteria are to blame. There have been 
cases reported of fatal transfusion-associated sepsis caused by Staphylococcus aureus and 
Clostridium perfringens. The source of Clostridium difficile was a donor, who frequently 
changed nappies of his newborn baby. Platelet concentrates can also contain other cocci, 
Corynebacterium pseudodiphtheriticum, also Gram-negative fermentative bacteria of the 
Pseudomonas genus. Recently, Listeria monocytogenes was isolated from an apheresis platelet 
concentrate (29). Although there have been no cases reported of isolating Listeria 
monocytogenes from other blood components, it must be remembered that iron, which is 
present in blood, e.g. in red blood cells, is conductive to the growth and virulence of this 
bacterium T(29).  
 Most bacteria are able to proliferate at 20oC – 24oC, but different bacteria have different 
growth dynamicity. In the case of S.aureus and Pseudomonas, after the first two days they 
start proliferating very quickly, whereas Enterococcus faecalis typically grows slowly and 
steadily. Transfusion-associated sepsis has been reported following transfusing platelet 
concentrates contaminated with Gram-positive bacteria (30).  
Sepsis caused by transfusing bacterially contaminated platelet concentrates is most 
common. Platelets are stored at room temperature and are a perfect medium for bacterial 
proliferation. The prevalence of symptomatic platelet transfusion-associated infections is 
1:5,000 in the case of pooled concentrates, and the relevant mortality rate ranges from 
1:70,000 to 1:100,000 transfusions (31,32). Table 5 shows bacteria most often detected in 
platelet concentrates. 
 
Blood component Bacteria 
Prevalence of detected 
bacteria that caused 
complications 
Platelet concentrate 
Staphylococcus epidermidis 
Salmonella choleraesuis 
Serratia marcescens 
Staphylococcus aureus 
Bacillus cereus 
Streptococcus viridans 
Other bacteria 
25 % 
13.5 % 
9.6 % 
9.6 % 
3.8 % 
5.8 % 
36.5 % 
Table 5. Bacteria and their prevalence in platelet concentrates 
Transfusion-associated bacterial sepsis usually manifests immediately after or still during 
transfusion. There have been seven cases reported of sepsis caused by Salmonella in 
platelet concentrate recipients, which manifested 5 – 12 days after transfusion (33). All the 
platelet units had been collected from the same donor who was later diagnosed with 
chronic ostitis. 
Bacteria contaminating blood components can be neutralized by such bacteriostatic factors 
as complement and phagocytosing cells. Yet, for many bacterial types, a concentration  
as small as 1 CFU/ml may be sufficient to proliferate (34). After an initial 2 – 3 day latency 
phase, bacteria rapidly proliferate to reach a concentration of 108 – 109 CFU/ml in the  
2nd – 5th day of storing.  
Haemovigilance studies carried out in many countries focus on severe adverse transfusion-
associated reactions caused by bacteria. Table 6 presents a summing-up of these studies. 
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Study 
Time of 
study 
Number of cases 
of blood 
component 
contamination 
Kind of blood 
component 
Number of 
deaths from 
transfusion-
associated 
sepsis 
SHOT 1996-1998 4 
1 red blood cell 
concentrate 
3 platelet 
concentrates 
0 
1 
French 
Hemovigilance 
1994-1999 185 
113 red blood 
cell concentrates 
89 platelet 
concentrates 
8 
10 
Bacthem 1996-1998 41 
25 red blood cell 
concentrates 
16 platelet 
concentrates 
6 
2 
BaCon 1998-2000 34 
5 red blood cell 
concentrates 
29 platelet 
concentrates 
3 
6 
Table 6. Findings of studies on bacterial contamination of blood components (35) 
The UK Serious Hazards of Transfusion (SHOT) study collects and analyzes all cases of 
transfusion-associated adverse reactions. In 1996 – 1998, there were 366 cases in all of 
adverse reactions registered within SHOT, four of which were transmitted by transfusing 
bacterial infection (36). Transfusion-associated sepsis developed after transfusing 1 unit of 
red blood cell concentrate contaminated with Serratia liquefaciens and three units of platelet 
concentrate which were contaminated with Escherichia coli, Bacillus cereus and Staphylococcus 
aureus. Transfusion-associated sepsis caused by S.aureus resulted in the patient’s death (36). 
In the French Hemovigilance Study carried out in 1994 – 1999, there were 730 transfusion-
associated bacterial infection events, out of which 185 were qualified in the end (89 
following red blood cell concentrate transfusions and 113 after platelet concentrate 
transfusions) (37). Eighteen recipients died after developing transfusion-associated bacterial 
sepsis. The risk for transfusion-associated bacterial reactions was estimated at 12.6:1,000,000 
blood component units. Bacteria isolated from red blood cell concentrates were Gram-
positive cocci (58%), mainly Staphylococcus spp and Streptococcus spp, and Gram-negative 
bacteria found in 32% of units. The both types of bacteria were found in 10% of cases. In 
platelet concentrates, Gram-negative bacteria were found in 36% of units, Gram-positive 
cocci in 42%, and other bacteria in 22% (37). Another French study (Bacthem) focused on 
years 1996 – 1998. During that time, there were 41 transfusion-associated cases analyzed. 25 
cases following transfusing red blood cell concentrates (4 deaths) and 16 cases following 
transfusing platelet concentrates (2 deaths). The bacteria contaminating the red blood cell 
concentrates in that study were mainly Gram-negative (52%) in contrast to 37% detected in 
the platelet concentrates. The risk for transfusion-associated sepsis was three times higher 
when platelet concentrates were transfused and 12 times higher when transfusing pooled 
platelet concentrates. Moreover, the risk for transfusion-associated bacterial sepsis was 
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higher when platelets had been stored longer than 1 day, and red blood cells for longer than 
eight days (38). One of the conclusions drawn from the study was that there is a strict 
correlation between the kind of blood component, duration of storing it and the risk for 
transfusion-associated bacterial sepsis (38). 
The American BaCon Study assessed the prevalence of transfusion-associated bacterial 
adverse reactions, kinds of bacterial contamination of blood components and risk factors for 
transfusion-associated bacterial sepsis occurrence. The study was conducted in 1998 – 2000 
(7). In that time, 34 cases of bacterial adverse reactions were assessed, nine of which were 
fatal. As the cause of transfusion-associated sepsis, the following bacteria were identified – 
Gram-positive: Staphylococcus epidermis (8 cases), S.aureus (4 cases), and Gram-negative: 
Escherichia coli (5 cases) and five cases where Serratia were identified (3 – S.marcescens,  
2 – S.liquefasciens) (7). The course of transfusion-associated bacterial sepsis was more rapid 
in patients who had been transfused blood components contaminated with Gram-negative 
bacteria than in those in whom the component transfused was contaminated with Gram-
positive bacteria. The researchers showed that transfusion-associated bacterial sepsis was 
developed five times more often after pooled platelet concentrates were transfused than 
after transfusing platelets from aphaeresis. In the BaCon study, there were 4 deaths resultant 
from sepsis following transfusion of aphaeresis platelet concentrates, i.e from one donor, 
and two deaths after transfusing pooled platelet concentrates (7,39). 
3. Sources of blood components bacterial contamination 
The most probable sources of blood component bacterial contamination are donor’s 
bacteremia, blood collection and processing procedures. Table 7 presents possible sources of 
bacterial contamination. 
 
Contamination source Contamination mechanism 
Blood donor 
Latent bacteremia 
Respiratory system flora 
Nasopharyngeal flora 
Blood collection procedures 
Normal skin flora 
Pathological, transient skin flora 
Practice of and equipment for blood 
collection 
Blood processing procedures 
Contaminated containers 
Open systems 
Infected enriching fluids 
Table 7. Sources and mechanisms of bacterial contamination of blood components 
Blood donors suffering from asymptomatic bacteremia or recovering from bacterial 
infections are a source of blood component bacterial contamination. Yersinia enterocolitica, a 
Gram-negative bacterium, can cause intestinitis with diarrhea of various intensity, increased 
temperature and abdominal pain. Yet, the infection is asymptomatic in most cases. Thus, 
such donors are a potential source of blood component contamination (40,41). Transfusion 
associated bacterial sepsis may be caused by other intestinal pathogens, such as 
Campylobacter jejuni and Salmonella Heidelberg, which induce donor’s bacteremia (18). They 
damage the intestinal mucosa and move into blood. In some people, only after they donated 
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blood were internal latent foci of infection detected. They were asymptomatic, yet they 
caused low-level bacteremia. There have been cases reported of sepsis after transfusing 
concentrate of platelets taken from donors who were during the incubation of bacterial 
infections of the respiratory tract and endocarditis (41). A donor can develop a short-time 
bacteremia after dentistry procedures. Staphylococcus aureus was detected in a platelet 
concentrate collected from a donor two hours after his tooth was treated conservatively (18). 
Staphylococcus aureus is not the only bacterium that can be the source of blood component 
contamination. There have been two cases reported where bacterial toxins were detected in 
the bags after transfused platelet concentrates. Recipients of this component developed 
manifestations of septic shock 15 and 20 minutes after their respective transfusions were 
begun (42). 
The procedures of collecting blood and its components are a source of platelet concentrate 
contamination mainly. Most bacteria detected in laboratory tests and reported as the cause 
of transfusion-associated sepsis are those which constitute the normal skin flora or those 
which transiently are present at the venopuncture site. An example of blood components 
being contaminated with bacteria that happened to be in the venopuncture site is a case of 
sepsis caused by Salmonella enterica. During an epidemiological investigation, it was found 
that the bacteria had originated form a platelet donor who had a snake. The bacteria were 
cultured from the recipient’s blood, form the bag where the blood component had been 
stored and the snake’s excrements, but Salmonella enterica was not cultured in the donor’s 
blood. The bacteria, most probably, was on the donor’s skin while platelet concentrate was 
collected by apheresis (43).  
There are known cases of severe transfusion-associated bacterial sepsis caused by red blood 
cell concentrates contaminated with Pseudomonas fluorescens originating from swabs used as 
cooling compresses on the venopuncture site in donors with low pain tolerance (44). 
Yet most blood components become contaminated because the venopuncture site has been 
disinfected insufficiently or because disinfectants were contaminated. There has been a case 
reported of red blood cell concentrate being contaminated with Burkholderia cepacia, because 
the chlorhexidine used for disinfecting the venopuncture was contaminated with this 
bacterium (45).  
Since disposable, sterile closed plastic systems for blood collection, processing and storage 
were introduced, there have been very uncommon situations when lack of adequate 
sterilization of a blood collection kit or contamination during blood processing resulted in 
contaminating a blood component. A practically invisible crack in a bag for blood or blood 
components can result in their contamination (10). 
4. Clinical picture 
Diagnosing transfusion-associated bacterial sepsis is difficult when the diagnosis is to be 
based only on clinical manifestations. That is why the criteria to diagnose this complication 
have been worked out and are presented in Table 8 (4). 
Transfusion-associated bacterial sepsis always manifests clinically in a very dramatic 
manner. The first symptoms (fever, shivering), which confirm the presence of bacteria in the 
recipient’s circulation usually appear within 2 hours following the start of the transfusion. 
The symptoms to follow are blood pressure drop, nausea, vomiting, diarrhea, and shock. 
Other symptoms, such as dyspnea or bleeding, result from bacteria inducing endotoxins. 
Delayed manifestations, which appear later than one day after transfusion, have been 
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reported following transfusing bacterially contaminated platelet concentrates (46). 
Transfusion-associated bacterial sepsis diagnosed too late is the most common cause of 
death. Early symptoms of sepsis may be diagnosed as non-infectious transfusion-associated 
adverse reactions, especially in neoplastic disease patients under immunosuppression, who 
have undergone numerous blood component transfusions. 
 
Within around 90 minutes after transfusion was started, one of the following symptoms 
appears: 
1. Fever ≥39oC or increase in body temperature by 2oC 
2. Shivering 
3. Tachycardia (≥120 beats per minute or increase by ≥40 bpm) 
4. Changes in systolic pressure (increase by ≥30 mmHg or decrease in comparison to 
baseline values) 
Table 8. Criteria to diagnose transfusion-associated bacterial sepsis 
The initial number of bacteria that is transfused in contaminated blood components is not 
large; it rarely exceeds 10 CFU/ml. That is why transfusing blood or its components within 
the first two days following donation is associated with a minimal risk for infectious 
transfusion-associated complications. Yet, a unique group of recipients constitute patients 
under immunosuppression, for whom even a very small number of bacteria are very 
dangerous. In most transfusion-associated bacterial reactions, the level of contamination in 
containers was at 106 – 108 CFU/ml. Such levels were found in platelet concentrates stored 
for 3 – 5 days, and red blood cell concentrates stored for at least three weeks. 
Severe sepsis with a rapid disease course is mostly caused by Gram-negative bacteria 
releasing an endotoxin which activates the immune system very strongly. Such bacteria are 
predominantly found in contaminated red blood cell concentrates and claim a very high 
mortality rate. 
Bacterial endotoxins – lipopolysaccharide (LPS) – are in the Gram-negative bacterial cellular 
wall and penetrate the environment after a bacterium disintegrates, and in a small amount, 
when a bacterium proliferates because then its cellular wall becomes less dense. They 
stimulate macrophages to secrete such inflammatory cytokines as TNFα, IL-1ß, IL-6, IL-8, 
which are responsible for numerous systemic reactions associated with septic shock. Patients 
who had been transfused red blood cell concentrate contaminated with Gram-negative 
bacteria had high plasma concentrations of these cytokines. Septic shock observed in recipients 
of contaminated concentrates must have resulted mainly from a massive release of cytokines 
rather than from the bacterial proliferation in the recipient’s organism (47). 
Bacterial strains responsible for severe transfusion-associated reactions may have certain 
features, such as resistance to phagocytosis or ability to activate complement, which enable 
them to proliferate in blood components. Asymptomatic, Gram-negative bacteremia in a 
blood donor is a phenomenon that accompanies alimentary tract infections and alimentary 
toxicosis. In the case of intestinal motility disorders, bacteria that are present on the surface 
of mucosa are able to penetrate into deeper tissue and blood. Bacteremia resultant from 
translocation usually does not pose a serious threat to donors whose immune system 
functions normally. Bacteria are eliminated from the circulation and sepsis does not 
develop. On the other hand, the consequences of transfusing a bacterially contaminated 
blood component may be very severe when the number of bacteria is very large or the 
recipient is a patient with low immunity. 
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The mortality rate is high and depends on the blood component, kind and amount of 
contaminating bacteria and patient’s clinical condition (including comorbidities). Other 
factors affecting the mortality rate are the ability to respond adequately to the infection and 
the kind of diagnostic and therapeutic procedures. Studies show that sepsis caused by 
transfusing contaminated red blood cell concentrates is particularly lethal (48). The factors 
that primarily negatively affect the defense against infections include chronic pulmonary 
diseases, neutropenia, immunosuppression, senility, and poor nutrition. 
5. Differentiating 
Differential diagnosis of transfusion-associated bacterial sepsis includes hemolytic reactions, 
febrile non-hemolytic reactions, TRALI, and sepsis unassociated with blood component 
transfusion. The diagnosis is based on culturing patient’s blood and a unit of the component 
transfused. The bacterial background of the transfusion-associated reaction is confirmed 
when the same bacterium is cultured from a container with the blood component and from 
patient’s blood. The similarity of the bacteria cultured from both sources is based on the 
bacterial DNA structure established with one of the methods for genetic typing (most often 
it is pulsed field gel electrophoresis – PFGE).  
6. Treating transfusion-associated bacterial sepsis 
The basic principles in treating transfusion-associated bacterial sepsis include early clinical 
suspicion, rigorous implementation of diagnostic procedures, appropriate causal therapy, 
inhibiting generalized inflammatory reactions predisposing to complications. 
When a fast growing fever appears, the transfusion should be discontinued, the container 
with the accompanying drains secured, and a blood sample taken from the patient so that 
microbiological tests can be done. The blood sample for culturing should be taken from 
another vein than the one into which the blood component has been transfused. 
Before microbiological tests findings are available, empiric therapy should be introduced. 
Antibiotic therapy should include such broad spectrum antibiotics as ß-lactams and 
aminoglycosides. When bacterially contaminated red blood cell concentrate transfusion-
associated sepsis is suspected, an antibiotic with anti-Pseudomonas activity should be 
introduced. Then targeted antibiotic therapy should be started. When a septic shock occurs, 
shock-controlling procedures should include monitoring hemodynamics, respiratory 
efficiency and kidney function. In fluid resuscitation, crystalloids and natural or artificial 
colloid solutions are used. The first transfusion consists of 500 – 1000 ml of crystalloids or 
300 – 500 ml of colloids during 30 minutes, and is repeated depending on such parameters 
as blood pressure, diuresis, and possibly volume overload. 
7. Prevention 
There are no absolutely reliable methods which can enable bacterial contamination of blood 
components to be detected effectively before transfusion. The methods used at present 
include four categories: (1) avoiding bacterial infections, (2) bacteriological testing of blood 
components, (3) inhibiting bacterial growth, and (4) techniques of pathogen inactivation. 
A method to prevent platelet transfusion-associated bacterial sepsis may be using platelets 
from one donor collected by apheresis instead of pooled. The findings of a 12-year study, 
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where adverse septic reactions after platelet transfusions were analyzed, showed that an 
increase in transfusing apheresis platelet concentrates was accompanied by a decrease in 
such reactions (39). Other studies have confirmed these observations pointing to the fact that 
bacterial contamination of pooled red blood cell concentrates is higher than in those 
collected from one donor (40). Yet, the findings of another paper described more bacterial 
contaminations in apheresis concentrates (49).  
7.1 Lowering the risk of donor’s asymptomatic bacteremia 
7.1.1 Avoiding bacterial infections 
Most people infected develop clinical manifestations of infection, which naturally 
disqualifies them as blood donors. The problem appears when a donor has an asymptomatic 
infection with bacteria in blood or transient, asymptomatic, bacteremia, e.g. after dental 
treatment or some diagnostic procedures. A key prophylactic action is to perform a 
thorough epidemiologic interview in the form of a questionnaire. The questionnaire should 
cover the largest possible number of situations which carry the risk for infection contracting 
and transmitting. Yet, even a best designed questionnaire is not always able to detect 
asymptomatic bacteremia in a donor and to prevent transfusing contaminated blood. 
Studies performed by CDC (Centers for Disease Control and Prevention) have shown that 
out of 6,000 people asked if they had experienced any alimentary tract disorders in the 
previous 30 days, 13% answered positively (50). Other studies showed that 1/3 of the 
donors in whose blood Yersinia enterocolitica was found had not complained of any gastro-
intestinal disorders (12). 
7.1.2 Lowering the risk for contaminating collected blood with donor’s skin flora 
The skin is richly colonized with bacterial flora, which is present in the superficial layer, on 
the epidermis, and in the deeper layers colonizing sebaceous glands, sudoriferous glands, 
and hair follicles. Even when the venopuncture site is prepared properly, not always is it 
possible to avoid contaminating the blood collected with the skin flora. Contamination with 
coagulase-negative Staphylococcus species is very common. Another commensal bacterium 
prevalent in the deeper skin layers and frequently contaminating blood taken is 
Propionibacterium. It is a bacterium that grows slowly in a low-oxygen environment (10). A 
few studies have shown that blood collected became contaminated with such bacteria as 
S.epidermidis, Pseudomonas fluorescens, Pseudomonas putida, despite the fact that skin 
bacteriological cultures harvested from the venopuncture site were aseptic (10). 
Skin disinfection at the venopuncture site is a specific way to prevent blood contamination; 
what is particularly important is not only using proper disinfectants but mainly disinfecting 
correctly and making sure the duration of particular stages of the disinfection process (time 
when a disinfectant is active) is as it should be. 
A venopuncture site is disinfected most effectively with iodine solutions. Yet, a large 
number of skin allergic reactions have resulted in iodine being replaced by chlorhexidine 
and isopropyl alcohol (51,52). Table 9 presents the effectiveness of different disinfectants. 
There should be at least two stages in the disinfection procedure with disinfectants whose 
manufacturers recommend the contact with the skin must be at least 30 seconds long. In 
practice, this means disinfectants must be used in the same manner they are used during 
preparations to surgery. 
What significantly diminishes the risk for contaminating collected blood with a donor’s skin 
flora is diversing the initial aliquot (around 20 – 30 ml) of the blood taken. This blood is used 
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for standard laboratory tests. Some authors claim such a practice may reduce the initial 
amount of bacteria in the blood taken even by 70 – 90%, but it does not eliminate the risk for 
its being contaminated (53,54,55). 
 
Number of 
bacterial 
colonies / dish 
Povidone 
iodine 
(% donors) 
Isopropyl 
alcohol 
and  iodine 
solution 
 (% donors) 
Chlorhexidine 
(% donors) 
Green soap 
and 
isopropyl 
alcohol 
(% donors) 
0 
1 – 10 
12 – 100 
> 100 
P 
(compared to 
povidone) 
34 – 49% 
35 – 43% 
10 – 14% 
0 – 13% 
63% 
34% 
2% 
1% 
< 0.001 
60% 
25% 
12% 
3% 
> 0.001 
0% 
17% 
47% 
36% 
< 0.001 
Table 9. Comparison of disinfectants efficacy (Goldman et al.) (46) 
7.2 Bacteriological testing of blood components 
Blood components are always tested bacteriologically in two situations: 
1. During an epidemiologic investigation; when sepsis signs occurred in a recipient during 
or after transfusion and it is suspected that an infectious agent has been transfused; 
2. Randomly, as a control study within the prophylaxis against transfusion-associated 
adverse reactions. 
The presence of bacteria in blood and its components can be detected with methods that are 
fast but not sensitive and have low specificity, e.g. macroscopic assessment, pH 
measurement, glucose concentration; or by using methods much more sensitive and 
specific, but requiring special equipment and highly qualified personnel. Table 10 presents 
different methods used to detect bacteria in blood components. 
 
1. Macroscopic assessment of blood components 
a) Red blood cell concentrate changes color 
b) Hemolisis in red blood cell concentrate 
c) Swirling phenomenon assessment in platelet concentrate 
2. Microscopic assessment of blood and its components (Gram staining, fluorescence 
microscopy) 
3. Measuring glucose concentration, pCO2, pO2 and pH while blood components are 
being stored 
4. Detecting bacteria endotoxins 
5. Microbiological testing 
6. Detecting bacterial genetic material 
7. Using flow cytometry to detect bacteria 
Table 10. Methods used to detect bacteria in blood components 
In bacterially contaminated red blood cell concentrates, some features of red blood cells are 
changed. While blood components were being assessed macroscopically, hemolisis and a 
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dark color have been observed in the concentrate with high levels of Yersinia enterocolitica, 
Enterobacter spp. and other Gram-negative bacteria (56,57,58). This phenomenon may result 
from bacteria using up the oxygen bound with hemoglobin in red blood cells. In 
contaminated blood components, methemoglobin concentration was found to be 2 – 4 times 
higher than in “healthy” components. In bacterially contaminated red blood cell 
concentrates, pH was found to be lower. 
Similar changes have been observed in platelet concentrates. Bacterial proliferation uses up 
glucose in the environment and, consequently, lowers pH (58). Oxygen concentration is 
observed to decrease and that of CO2 to increase (35,58). Yet, changes in these parameters do 
not necessarily mean there are bacteria present, because leukocytes and platelets also take 
up glucose and oxygen form the environment. The metabolism of platelets in stored 
concentrates is very vivid. That is why simple and direct measurement of these parameters 
does not indicate unambiguously bacteria are present. The sensitivity of the macroscopic 
assessment of blood components is around 108 CFU/ml. One of the studies on bacterial 
contamination of blood components showed the method was more sensitive. Bacterial 
contamination of 1.8x104 to 1.6x109 CFU/ml was found in the whole blood which earlier at 
macroscopic assessment was suspected of being contaminated (57). 
In bacterially contaminated platelet concentrates, the “swirling” phenomenon is observed, 
i.e. platelet blinking or twinkling. When platelets are seen in a light beam going through 
blood, they swirl and reflect light and thus the swirling phenomenon is produced. This 
phenomenon disappears or is attenuated when there are bacteria in platelet concentrate, 
which lower pH (35). 
Blood components are assessed microscopically for detecting bacteria in both red blood cell 
concentrates and platelet concentrates. The assessment is based on Gram staining. 
Unfortunately, this method’s sensitivity is very low. It is possible to detect bacteria when 
their concentration is 105 – 106 CFU/ml (59). When the two methods of detecting bacteria in 
blood were compared (culturing on bacteriological medium and microscopic assessment), 
more than half of the samples where bacteria were cultured were negative microscopically 
(60). The use of acridine orange to detect bacteria in blood components has also been 
reported (61). 
Genetic methods, which detect bacterial genetic material, are of a very high sensitivity. 
Methods based on the polymerase chain reaction (PCR) detect the genetic material of S.aureus, 
E.coli, B.cereus and K.pneumoniae in platelet concentrates with the sensitivity of 10 
CFU/container (62). Other genetic methods use probes directed at a precisely defined bacterial 
DNA fragment, mainly 16SrDNA. They enable many different bacteria to be detected in blood 
components (63). The presence of marked probes is detected with chemiluminescence or 
electroluminescence. The test lasts a few hours, so theoretically it might be performed before 
each transfusion, and then the duration of storing blood components could be more “flexible” 
(10). The advantage of genetic methods is their speed and high sensitivity. Their disadvantage 
is the fact that they detect bacteria both alive and non-viable.  
Flow cytometry is a method of the speed and sensitivity similar to those of genetic methods. 
Moreover, it differentiates bacteria which are alive from those which are dead. 
At present, bacteria in blood components can be detected routinely with the method of 
marking them with fluorescence dyes and found on a special membrane (after filtration). 
The principle of this method is used in an automatic system where bacteria can be detected 
within 30 – 72 hours since blood collection. The time of the test is short, around 90 minutes, 
and detects bacterial contamination at 105 CFU/ml (64). 
www.intechopen.com
 
Transfusion-Associated Bacterial Sepsis 
 
61 
The present “gold standard” in detecting bacteria in blood and its components is considered 
to be a method based on measuring CO2 concentration in a bag with biological medium 
with an appropriate amount of the platelet concentrate tested. An increase in pCO2 is 
detected (as a marker of bacterial presence) by the calorimetric index (10). 
None of the methods described above is able to detect bacterial contamination of blood 
components if its concentration is very low. Donor’s subclinical bacteremia in its initial phase 
has bacterial concentration at ≤10 CFU/ml and is undetectable. That is why blood components 
are tested for bacterial contamination 24 hours after blood was collected. Although this 
practice delays obtaining the result of the test, it allows the cause of the contamination to be 
found and transfusion-associated bacterial sepsis to be avoided. Because of an increased risk 
for platelet concentrate transfusion-associated adverse reactions, in March 2004 FDA ruled that 
in the USA all platelet concentrates which are to be transfused have to be tested first (65). 
Similar regulations are in effect in some European countries.  
7.3 Modifying the conditions of storing blood components 
Platelet concentrate is a blood component in which bacteria have good conditions to 
survive. Lowering the temperature at which platelet concentrate is stored would inhibit 
bacterial proliferation and reduce the risk for transfusion-associated sepsis (4 – 6oC), but it 
would also affect negatively platelet haemostatic features and their survival in the 
circulation. This mechanism became known only recently (66). Short-time exposure of 
platelets to cold results in platelets clustering glycosylated protein GP1B on the surface of 
the chilled platelets. The aggregation process is induced by the binding of glycoprotein with 
receptors on macrophages, which immobilizes platelets. The phenomenon is transitional if 
platelets are not stored in the cold for longer than two hours. If platelet concentrate is stored 
in the cold for longer than 48 hours, platelet functions are distorted by competitive blockade 
of the asialo receptors, which results in platelet survival time in the circulation becoming 
shorter (66). Routinely, platelet concentrates are stored at 20 – 24 oC for up to 5 days, but 
after each unit is tested bacteriologically, the storing period may be prolonged to 7 days. 
There are opinions heard universally that the present guidelines should be changed and the 
duration of blood component storage should be shortened (10). 
Most severe cases of transfusion-associated bacterial sepsis have been reported after 
transfusing red blood cell concentrates stored for over 2 weeks, because at the temperature 
of 2 – 6oC bacterial growth and metabolism are either inhibited or considerably slower. The 
temperature of 4oC does not stop Yersinia, Pseudomonas and Serratia from growing. A few 
centers have introduced “a preceding period” to red blood cell concentrate storage. The idea 
was to leave red blood cells in room temperature for 5 – 7 hours, and then perform a 
bacteriological test. It turned out that a longer time of incubation (about 7 hours) at room 
temperature improved detection of Yersinia enterocolitica, whereas such bacteria as 
Enterococcus or Klebsiella were much more numerous after 4 hours of incubation (67,68). 
The temperature of 2 to 6oC is an inhibiting factor not only for bacteria. Cellular activity and 
the activity of immune system factors in fresh blood are inhibited too. That is why it is 
beneficial to leave the blood collected at room temperature for 2 – 4 hours so that natural 
mechanisms could act and destroy bacteria (12). 
7.4 Inactivation of bacteria contaminating blood components 
The techniques used to reduce bacteria contaminating blood components are new methods 
able to limit the risk for transfusion-associated bacterial sepsis. These methods are effective 
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both when well-known infectious agents are encountered and also when the agents have so 
far been neglected from the transfusiology point of view, or even those which have not been 
discovered yet. They should possess the following features: 
• They should inactivate a broad spectrum of bacteria; 
• They should not change the therapeutic properties of a blood component; 
• Reagents and photoproducts, whose traces may remain after the reduction process is 
finished, must not be toxic to recipients; 
• The costs of implementation should be proportional to their effectiveness (69,70) 
The effectiveness assessment is based on comparing the number of model bacteria added to 
blood components before and after inactivation. The method is believed to be effective if the 
number of bacteria is diminished by 5 – 6 log10 in reference to the baseline values (71, 72). 
In in vitro studies, the parameter defining the effectiveness of the method is the reduction 
index (R), which is a negative logarithm (Y) of the ratio between the number of bacteria in 
the baseline material to the number of bacteria after reduction plus/minus 1: 
R = - log (Y) ± 1 
The reduction index is dependent on many factors. The most important are: baseline 
bacterial concentration, their type and kind of blood component. 
Naturally, it is not enough to establish that a particular method of pathogen reduction is 
effective. It is necessary to carry out in vitro tests of particular blood components before and 
after reduction (69). Such tests aim to establish to what extent blood components change 
their functional and metabolic properties during storing. The methods of bacterial reduction 
must not distort biochemical metabolic transformations of red blood cells and platelets. If a 
method is to be applied clinically, a blood component after pathogen reduction with a 
particular method should be safe, therapeutically effective and must not cause adverse 
reactions (69). 
The methods used in order to limit transmitting bacteria by contaminated blood 
components can be divided into two groups. In the first group, there are those procedures 
which inactivate bacteria. Inactivation destroys their capsules or damages their DNA/RNA, 
which prevents their proliferation. One of such methods is the Solvent/detergent method 
used mainly to reduce pathogens in the capsule. 
The second group of methods focuses on eliminating the infectious factor completely or on 
lowering its amount so that it would not be infectious any longer. They are methods of 
photoinactivation with visual or UV radiation and such radiosensitive compounds as 
psolarens, as well as filtration. They are used to reduce pathogens in platelet and red blood 
cell concentrates (73). 
The methods of inactivation with riboflavin are being clinically tested.  The methods used 
for red blood cell concentrates must not need light exposure because light is absorbed by 
hemoglobin.  
Clinical tests in the form of transfusing platelet concentrates inactivated with psolarens have 
shown lack of toxicity and their photoproducts. Photoinactivation with psolarens proves to 
be an effective method that inactivates a broad spectrum of both Gram-negative and Gram-
positive bacteria. Platelets inactivated in this way have been proved sterile for the whole 
time of storage and the metabolic functions of these blood cells were preserved even in the 
7th day of storing. Yet, what has to be considered as negative is an approximate 10% loss in 
the number of platelets after the process of inactivation (71). 
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The methods of pathogen reduction in blood components have been recommended as 
priorities to be applied and further studied so that the safety of blood and its components 
will improve (74,75). 
Filtration, used to limit bacterial contamination in blood components, results in the removal 
of leukocytes together with bacteria inside them. Bacteria may adhere to leukocytes on the 
filter too. Free forms of bacteria can be also removed by direct adhesion to the filter material. 
Several in vitro studies have shown that filters which reduce the number of leukocytes are able 
to rid contaminated red blood cell concentrates or whole blood of bacteria (38,49,76). The 
blood units, into which Y.enterocolitica bacteria were added a few hours after collection, and 
which underwent filtering so that leukocytes would be removed, contained fewer bacteria 
than those which had not been filtered. On the other hand, diminishing the number of 
leukocytes by filtering them out is less effective in removing bacteria from platelet 
concentrates (76). The number of bacteria grew slower in low-leukocyte platelet concentrates, 
but after one day the concentration of bacteria contaminating this blood component did not 
differ significantly from others. Similarly, molecular studies of bacterial RNA showed the 
same growth rate of bacteria in platelet concentrates contaminated with S.epidermidis (77). 
Filters which reduce the number of leukocytes can catch bacteria directly, which is illustrated 
by the fact that Staphylococcus xylosus can be removed from blood components which were 
filtered previously (77). Yet, other studies have proved that filtering blood is able to reduce the 
number of bacteria in blood components, but it is never able to filter out the contamination 
fully (78). Filtering out leukocytes from blood components can also eliminate phagocytized 
bacteria inside them (76). If granulocytes disintegrate before bacteria are destroyed, they can 
get into the blood again. The optimal time to perform filtration is probably 2 to 12 hours 
following blood collection. It is the time for phagocytosis and reduction of leukocytes before 
viable bacteria are released from them (77). This mechanism has been used to explain why 
bacteria are found in the blood components which were previously considered 
uncontaminated. The interests of the haemovigilance study program included the benefits 
resulting from leukocyte reduction in blood components. The results revealed that the 
percentage of bacterially contaminated blood components had been considerably lowered 
(3.8% before filtering vs 1.7% after filtering) and the number of transfusion-associated bacterial 
sepsis cases significantly reduced (71% vs 24%) (54). 
8. Summing-up 
Bacterial contamination of blood components is a cause of transfusion-associated sepsis. The 
components which most often become contaminated are those of red blood cells and of 
platelets. Blood components often become bacterially infected during blood collection from a 
donor; more seldom in the case of asymptomatic bacteremia or faulty blood processing. The 
methods used currently, which are based on culturing, visual assessment of a component, 
appropriate selection of donors, venopuncture site disinfection techniques, more often than 
not are able to prevent transfusion-associated bacterial sepsis. The techniques of pathogen 
inactivation may turn out to be promising in preventing bacterial infections. 
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